GlassScriptPhysician profile
Renata Lerer
NPI 1518427178
$1,322.45
in general payments reported to CMS, 2019-2025
10 companies · $527 in 2025
The $527 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2024: $680 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $402.36 | 2025 | Rezdiffra |
| Mallinckrodt Hospital Products INC. | $182.72 | 2024-2025 | Terlivaz |
| Gilead Sciences, INC. | $150.00 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $129.15 | 2024 | Iqirvo |
| Eisai INC. | $115.50 | 2022 | |
| Alexion Pharmaceuticals, INC. | $105.34 | 2024 | |
| Lilly USA, LLC | $102.23 | 2024 | Omvoh |
| Janssen Biotech, INC. | $79.32 | 2024 | Stelara |
| W. L. Gore & Associates, INC. | $36.85 | 2025 | Gore Viatorr Tips Endoprosthesis |
| Abbvie INC. | $18.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Lerer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.